CORBUS PHARMACEUTICALS HOLDI
CRBP · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $5.26
- Today’s Low
- $4.76
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $5.35
- Previous Close
- $5.27
- Volume
- 1.01M
- Market Cap
- $101.92M
- P/E Ratio
- --
- EPS
- $-6.17
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, UNITED STATES, 02062
- Country
- US
- Listing Date
- 2014-10-24
- Fiscal Year End
- December
- Shares Outstanding
- 18.53M
- CIK
- 0001595097
- Website
- www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$36.19M
2026-03-31
$24.25M
2025-12-31
$21.96M
2025-09-30
$24.41M
Net Income
2026-06-30
-$35.03M
2026-03-31
-$22.96M
2025-12-31
-$20.55M
2025-09-30
-$23.34M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.81
2026-03-31
$-1.23
2025-12-31
$-1.25
2025-09-30
$-1.90
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$34.98M
2026-03-31
-$22.92M
2025-12-31
-$20.5M
2025-09-30
-$23.29M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $36.19M | $24.25M | $21.96M | $24.41M |
| Net Income | -$35.03M | -$22.96M | -$20.55M | -$23.34M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.81 | $-1.23 | $-1.25 | $-1.90 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$34.98M | -$22.92M | -$20.5M | -$23.29M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.